205 related articles for article (PubMed ID: 31524012)
41. Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery.
Guo J; Gao X; Su L; Xia H; Gu G; Pang Z; Jiang X; Yao L; Chen J; Chen H
Biomaterials; 2011 Nov; 32(31):8010-20. PubMed ID: 21788069
[TBL] [Abstract][Full Text] [Related]
42. Anti-tumor efficiency of paclitaxel and DNA when co-delivered by pH responsive ligand modified nanocarriers for breast cancer treatment.
Yu D; Li W; Zhang Y; Zhang B
Biomed Pharmacother; 2016 Oct; 83():1428-1435. PubMed ID: 27592131
[TBL] [Abstract][Full Text] [Related]
43. A novel size-tunable nanocarrier system for targeted anticancer drug delivery.
Li Y; Xiao K; Luo J; Lee J; Pan S; Lam KS
J Control Release; 2010 Jun; 144(3):314-23. PubMed ID: 20211210
[TBL] [Abstract][Full Text] [Related]
44. Anti prostate cancer therapy: Aptamer-functionalized, curcumin and cabazitaxel co-delivered, tumor targeted lipid-polymer hybrid nanoparticles.
Chen Y; Deng Y; Zhu C; Xiang C
Biomed Pharmacother; 2020 Jul; 127():110181. PubMed ID: 32416561
[TBL] [Abstract][Full Text] [Related]
45. Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model.
Moosavian SA; Abnous K; Badiee A; Jaafari MR
Colloids Surf B Biointerfaces; 2016 Mar; 139():228-36. PubMed ID: 26722819
[TBL] [Abstract][Full Text] [Related]
46. Aptamer-functionalized hybrid nanoparticle for the treatment of breast cancer.
Powell D; Chandra S; Dodson K; Shaheen F; Wiltz K; Ireland S; Syed M; Dash S; Wiese T; Mandal T; Kundu A
Eur J Pharm Biopharm; 2017 May; 114():108-118. PubMed ID: 28131717
[TBL] [Abstract][Full Text] [Related]
47. Self-Assembled Tumor-Penetrating Peptide-Modified Poly(l-γ-glutamylglutamine)-Paclitaxel Nanoparticles Based on Hydrophobic Interaction for the Treatment of Glioblastoma.
Yu J; Sun L; Zhou J; Gao L; Nan L; Zhao S; Peng T; Han L; Wang J; Lu W; Zhang L; Wang Y; Yan Z; Yu L
Bioconjug Chem; 2017 Nov; 28(11):2823-2831. PubMed ID: 28968068
[TBL] [Abstract][Full Text] [Related]
48. Ganoderma lucidum-derived polysaccharide enhances coix oil-based microemulsion on stability and lung cancer-targeted therapy.
Guo J; Yuan C; Huang M; Liu Y; Chen Y; Liu C; Chen Y
Drug Deliv; 2018 Nov; 25(1):1802-1810. PubMed ID: 30343605
[TBL] [Abstract][Full Text] [Related]
49. Cellular Uptake and Cytotoxic Effect of Epidermal Growth Factor Receptor Targeted and Plitidepsin Loaded Co-Polymeric Polymersomes on Colorectal Cancer Cell Lines.
Goñi-de-Cerio F; Thevenot J; Oliveira H; Pérez-Andrés E; Berra E; Masa M; Suárez-Merino B; Lecommandoux S; Heredia P
J Biomed Nanotechnol; 2015 Nov; 11(11):2034-49. PubMed ID: 26554161
[TBL] [Abstract][Full Text] [Related]
50. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting.
Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M
Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430
[TBL] [Abstract][Full Text] [Related]
51. Down-regulation of survivin and hypoxia-inducible factor-1 α by β-elemene enhances the radiosensitivity of lung adenocarcinoma xenograft.
Li G; Xie B; Li X; Chen Y; Wang Q; Xu Y; Xu-Welliver M; Zou L
Cancer Biother Radiopharm; 2012 Feb; 27(1):56-64. PubMed ID: 22248028
[TBL] [Abstract][Full Text] [Related]
52. A novel paclitaxel microemulsion containing a reduced amount of Cremophor EL: pharmacokinetics, biodistribution, and in vivo antitumor efficacy and safety.
Wang Y; Wu KC; Zhao BX; Zhao X; Wang X; Chen S; Nie SF; Pan WS; Zhang X; Zhang Q
J Biomed Biotechnol; 2011; 2011():854872. PubMed ID: 21331356
[TBL] [Abstract][Full Text] [Related]
53. In vitro combination characterization of the new anticancer plant drug beta-elemene with taxanes against human lung carcinoma.
Zhao J; Li QQ; Zou B; Wang G; Li X; Kim JE; Cuff CF; Huang L; Reed E; Gardner K
Int J Oncol; 2007 Aug; 31(2):241-52. PubMed ID: 17611679
[TBL] [Abstract][Full Text] [Related]
54. β-elemene sensitizes hepatocellular carcinoma cells to oxaliplatin by preventing oxaliplatin-induced degradation of copper transporter 1.
Li X; Lin Z; Zhang B; Guo L; Liu S; Li H; Zhang J; Ye Q
Sci Rep; 2016 Feb; 6():21010. PubMed ID: 26867799
[TBL] [Abstract][Full Text] [Related]
55. Discovery of novel antitumor nitric oxide-donating β-elemene hybrids through inhibiting the PI3K/Akt pathway.
Chen J; Wang T; Xu S; Zhang P; Lin A; Wu L; Yao H; Xie W; Zhu Z; Xu J
Eur J Med Chem; 2017 Jul; 135():414-423. PubMed ID: 28463784
[TBL] [Abstract][Full Text] [Related]
56. Neovasculature and circulating tumor cells dual-targeting nanoparticles for the treatment of the highly-invasive breast cancer.
Yao J; Feng J; Gao X; Wei D; Kang T; Zhu Q; Jiang T; Wei X; Chen J
Biomaterials; 2017 Jan; 113():1-17. PubMed ID: 27794222
[TBL] [Abstract][Full Text] [Related]
57. Synergistic Cytotoxicity of β-Elemene and Cisplatin in Gingival Squamous Cell Carcinoma by Inhibition of STAT3 Signaling Pathway.
Huang C; Yu Y
Med Sci Monit; 2017 Mar; 23():1507-1513. PubMed ID: 28355175
[TBL] [Abstract][Full Text] [Related]
58. Co-delivery of paclitaxel and cetuximab by nanodiamond enhances mitotic catastrophe and tumor inhibition.
Lin YW; Raj EN; Liao WS; Lin J; Liu KK; Chen TH; Cheng HC; Wang CC; Li LY; Chen C; Chao JI
Sci Rep; 2017 Aug; 7(1):9814. PubMed ID: 28852020
[TBL] [Abstract][Full Text] [Related]
59. Transferrin conjugated poly (γ-glutamic acid-maleimide-co-L-lactide)-1,2-dipalmitoylsn-glycero-3-phosphoethanolamine copolymer nanoparticles for targeting drug delivery.
Zhao C; Liu X; Liu J; Yang Z; Rong X; Li M; Liang X; Wu Y
Colloids Surf B Biointerfaces; 2014 Nov; 123():787-96. PubMed ID: 25454663
[TBL] [Abstract][Full Text] [Related]
60. Patrinia scabiosaefolia induces mitochondrial-dependent apoptosis in a mouse model of colorectal cancer.
Liu L; Shen A; Chen Y; Wei L; Lin J; Sferra TJ; Hong Z; Peng J
Oncol Rep; 2013 Aug; 30(2):897-903. PubMed ID: 23754194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
